These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36596540)

  • 1. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
    Yamazaki D
    Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan].
    Kimura H
    Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.
    Ishida S
    Front Toxicol; 2021; 3():657765. PubMed ID: 35295097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
    Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
    Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment].
    Naraoka H
    Nihon Yakurigaku Zasshi; 2023; 158(2):187-192. PubMed ID: 36858504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of MPS research toward social implementation].
    Sakai Y; Kimura H
    Nihon Yakurigaku Zasshi; 2022; 157(5):330-334. PubMed ID: 36047147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator.
    Kanamori T; Sugiura S; Sakai Y
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):40-42. PubMed ID: 29217459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
    Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
    Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphysiological systems for human aging research.
    Park S; Laskow TC; Chen J; Guha P; Dawn B; Kim DH
    Aging Cell; 2024 Mar; 23(3):e14070. PubMed ID: 38180277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pumped and pumpless microphysiological systems to study (nano)therapeutics.
    Lee EJ; Krassin ZL; Abaci HE; Mahler GJ; Esch MB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1911. PubMed ID: 37464464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
    Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
    ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of microphysiological systems for nonclinical evaluation of cell therapies.
    Candarlioglu PL; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan KA; Fellows MD; Pointon A; Kojala K
    ALTEX; 2024; 41(3):469-484. PubMed ID: 38746991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
    Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
    Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
    Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
    ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development.
    Tomlinson L; Ramsden D; Leite SB; Beken S; Bonzo JA; Brown P; Candarlioglu PL; Chan TS; Chen E; Choi CK; David R; Delrue N; Devine PJ; Ford K; Garcia MI; Gosset JR; Hewitt P; Homan K; Irrechukwu O; Kopec AK; Liras JL; Mandlekar S; Raczynski A; Sadrieh N; Sakatis MZ; Siegel J; Sung K; Sunyovszki I; Van Vleet TR; Ekert JE; Hardwick RN
    Adv Biol (Weinh); 2024 Aug; 8(8):e2300131. PubMed ID: 37814378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in developing microphysiological systems for biological product assessment.
    Mansouri M; Lam J; Sung KE
    Lab Chip; 2024 Feb; 24(5):1293-1306. PubMed ID: 38230512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.